ROQUETTE PHARMA SOLUTIONS
Spring House Innovation Park
727 Norristown Road, Building 9, Floor 2
Lower Gwynedd Township, PA 19002
Roquette Pharma Solutions offers a large and diverse portfolio of reliable, plant-based excipients, nutraceutical active ingredients, active pharmaceutical ingredients, high-quality and multi-compendial specialty ingredients, and pyrogen-free carbohydrates. Suitable for a range of applications encompassing prescription and over-the-counter drugs, generics, nutraceuticals, biopharmaceuticals, injectables and dialysis, our solutions include:
US Innovation Center Near Philadelphia
Our Pharmaceutical Innovation Center in the US is dedicated to advancing the research of drug delivery systems for oral prescription drugs while improving speed to market. It complements the advanced biopharmaceutical research conducted at our Singapore Innovation Center, as well as our central R&D facility in France.
The site also serves as an Applied Science and Customer Technical Support (CTS) center for advanced research in drug delivery systems for oral prescription (small molecule) drugs, as well as nutraceuticals. One of the main goals for this laboratory is developing drug delivery technologies that increase patient compliance. This facility allows us to work in close partnership with our US customers and partners to develop essential drug solutions and get them to market faster.
OUR MARKET SEGMENTS
Injectables, Dialysis and Specialty APIs
SEE OUR SCIENCE
CASE STUDY: Tableting Study for Orodispersible Tablets ODTsLearn more about PEARLITOL® Flash co-processed mannitol-starch performances in orodispersible tablets. A case study proposed by Roquette
CASE STUDY: Binder for continuous wet granulation: case of soluble system
Learn more about LYCOAT® RS (modified pea starch) as binder in continuous wet granulation. A case study proposed by Roquette
CASE STUDY: Binder selection for continuous wet granulation: case of insoluble system
Learn more about LYCOAT® RS 720 and CLEARGUM® CO 03 modified starches as continuous wet granulation binders of paracetamol. A case study proposed by Roquette.
CASE STUDY: Pea Starch, a Versatile Soft Capsule Shell Material – Study of Marketing Differentiation Options with Color Agents
Learn more about LYCAGEL® VS 720 PREMIX, hydroxypropyl pea starch based vegetal soft capsule shell material. A case study proposed by Roquette.
CASE STUDY: Accelerated Stability Study of Biopharma Grade Hydroxypropyl β-Cyclodextrin in Solution
Learn more about KLEPTOSE® HP and HPB biopharma grades stability in solution.
CASE STUDY: Polysorbates versus Hydroxypropyl Beta-Cyclodextrin: Comparative Study on Excipient Stability and Stabilization Benefits on Monoclonal Antibodies
Learn more about KLEPTOSE® HP, HPB and HPB-LB hydroxypropyl beta-cyclodextrin stabilization benefits on monoclonal antibodies.
CASE STUDY: Polysorbates versus Hydroxypropyl beta Cyclodextrin: Comparative Study on Excipient Stability and Stabilization Benefits on Monoclonal Antibodies
Learn more about KLEPTOSE® HP, HPB and HPB-LB hydroxypropyl beta-cyclodextrin stabilization benefits on monoclonal antibodies. A white paper proposed by Roquette
CASE STUDY: Compaction Stability of Spray-Dried Mannitol’s containing α and β Crystalline Polymorphs
Learn more about PEARLITOL® 100 SD and 200 SD mannitol performances stability upon storage.
Posted Date: 12/1/2023
This record has been viewed 1616 times.